Transmedics Group Inc (NASDAQ:TMDX) shares, rose in value on Thursday, February 13, with the stock price up by 2.45% to the previous day’s close as strong demand from buyers drove the stock to $71.22.
Actively observing the price movement in the last trading, the stock closed the session at $69.52. The PE ratio was 76.30 over 12-month period. Referring to stock’s 52-week performance, its high was $177.37, and the low was $55.00. On the whole, TMDX has fluctuated by 13.88% over the past month.
With the market capitalization of Transmedics Group Inc currently standing at about $2.39 billion, investors are eagerly awaiting this quarter’s results, scheduled for in March.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 429.5M, with a low estimate of 105M and a high estimate of 111.42M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 109.49M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that TMDX’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of TMDX currently trading nearly 7.41% and 6.98% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 55.26, while the 7-day volatility ratio is showing 6.26% which for the 30-day chart, stands at 6.36%. Furthermore, Transmedics Group Inc (TMDX)’s beta value is 2.14, and its average true range (ATR) is 4.45.
A comparison of Transmedics Group Inc (TMDX) with its peers suggests the former has fared considerably weaker in the market. TMDX showed an intraday change of 2.45% in last session, and over the past year, it shrunk by -19.06%%.
Data on historical trading for Transmedics Group Inc (NASDAQ:TMDX) indicates that the trading volumes over the past 3 months, they’ve averaged 2.02 million. According to company’s latest data on outstanding shares, there are 33.56 million shares outstanding.
Nearly 3.41% of Transmedics Group Inc’s shares belong to company insiders and institutional investors own 107.02% of the company’s shares. The stock has risen by 14.23% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the TMDX stock heading into the next quarter.
